BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | 43.91%1.69B | -11.47%1.25B | -25.48%1.21B | -14.29%1.49B | -34.37%1.17B | -9.14%1.42B | 37.78%1.62B | 65.45%1.73B | --1.79B | 151.02%1.56B |
Notes receivable and accounts receivable | 24.27%1.16B | 29.00%1.19B | 31.98%1.26B | 4.38%1.02B | -5.71%935.87M | -11.41%920.59M | -8.96%953.3M | -11.99%977.36M | --992.56M | 6.33%1.04B |
-Notes receivable | 82.43%146.22M | 3.74%132.29M | 69.34%166.39M | -48.70%52.53M | -48.75%80.15M | -33.04%127.52M | -54.71%98.26M | -55.09%102.4M | --156.38M | -12.97%190.44M |
-Accounts receivable | 18.82%1.02B | 33.06%1.06B | 27.69%1.09B | 10.59%967.65M | 2.34%855.72M | -6.56%793.06M | 3.00%855.04M | -0.86%874.96M | --836.18M | 11.89%848.76M |
Other receivables (including interest and dividends) | 8.99%29.95M | 35.53%29.78M | 35.36%28.17M | 3.23%25.53M | -11.03%27.48M | 155.64%21.97M | -5.78%20.81M | 108.46%24.73M | --30.89M | -38.03%8.6M |
-Dividend receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.2M | ---- | ---- |
-Accrued interest receivable | ---- | ---- | --2.46M | --2.46M | --6.44M | ---- | ---- | ---- | ---- | ---- |
-Other receivable | ---- | ---- | ---- | -1.98%23.07M | ---- | 155.64%21.97M | ---- | --23.53M | ---- | -38.03%8.6M |
Contractual assets | -29.52%19.43M | -8.27%29.16M | -3.07%26.18M | 31.66%26.86M | 0.61%27.57M | -5.74%31.79M | -20.75%27.01M | -15.44%20.4M | --27.41M | 57.69%33.72M |
Advance payment | 41.82%39.16M | 25.88%47.56M | -34.32%33.37M | -17.57%28.72M | -9.20%27.62M | -25.74%37.78M | -29.99%50.8M | 18.33%34.85M | --30.41M | 17.17%50.87M |
Inventories | 11.55%72.34M | 12.01%78.25M | 20.89%67.65M | 40.79%76.98M | 12.73%64.85M | 11.99%69.86M | -7.19%55.96M | -19.23%54.67M | --57.53M | 26.10%62.38M |
Receivable financing | -49.22%10.1M | 58.37%46.46M | 122.87%37.9M | -54.67%17.88M | -21.96%19.88M | 36.48%29.34M | -49.39%17.01M | 36.23%39.45M | --25.47M | -66.99%21.49M |
Other current assets | -56.58%64.04M | -44.10%92.23M | 385.67%141.16M | 432.70%225.07M | 400.88%147.5M | 606.36%165M | 2.10%29.06M | 102.49%42.25M | --29.45M | 24.82%23.36M |
Total current assets | 27.32%3.08B | 2.69%2.76B | 0.92%2.8B | -0.69%2.91B | -18.68%2.42B | -3.78%2.69B | 12.13%2.78B | 25.02%2.93B | --2.98B | 54.55%2.8B |
Non Current assets | ||||||||||
Investment real estate | -8.62%17.43M | -8.44%17.84M | -8.27%18.25M | -2.06%18.66M | -1.96%19.08M | -1.85%19.49M | 0.97%19.9M | -4.89%19.06M | --19.46M | -4.93%19.85M |
Long-term equity investment | -2.13%278.23M | -2.81%277.01M | -4.14%274.16M | -3.64%278.47M | -2.52%284.28M | -2.35%285.03M | -2.01%286.02M | -1.07%288.97M | --291.64M | -5.86%291.89M |
Fixed assets | ---- | ---- | ---- | 37.17%4.7B | ---- | 32.55%4.24B | ---- | 3.29%3.43B | ---- | 25.83%3.2B |
Constru in process | ---- | ---- | ---- | -84.29%70.09M | ---- | 45.55%444.11M | ---- | 538.91%446.27M | ---- | -37.84%305.12M |
Intangible assets | 58.78%5.59M | 58.52%5.99M | 17.21%2.99M | 19.35%3.26M | 25.40%3.52M | 26.91%3.78M | -15.85%2.55M | -16.29%2.73M | --2.81M | -4.60%2.98M |
Goodwill | 0.00%1.34M | 0.00%1.34M | 0.00%1.34M | 0.00%1.34M | 0.00%1.34M | 0.00%1.34M | 0.00%1.34M | 0.00%1.34M | --1.34M | 0.00%1.34M |
Long deferred expense | -32.45%1.16M | -30.81%1.28M | -26.71%1.44M | -21.24%1.6M | -20.29%1.72M | -19.48%1.84M | 68.09%1.97M | 80.31%2.03M | --2.16M | 17.08%2.29M |
Deferred tax assets | 42.50%2.34M | 43.55%2.41M | -21.53%1.53M | -13.35%1.6M | -63.41%1.64M | -62.80%1.68M | -61.61%1.95M | -62.88%1.85M | --4.49M | -10.22%4.52M |
Usufruct assets | -44.10%13.11M | -39.46%15.87M | -34.90%18.66M | -29.63%21.41M | -25.86%23.45M | -23.69%26.22M | -23.36%28.66M | -23.11%30.42M | --31.63M | 7.26%34.36M |
Other non current assets | -61.96%61.08M | -62.99%67.33M | -45.13%74.72M | -73.82%49.87M | -49.28%160.57M | -51.74%181.92M | -70.35%136.16M | -65.81%190.45M | --316.58M | -26.17%376.95M |
Total non current assets | 4.99%5.43B | 4.55%5.45B | 14.45%5.32B | 16.71%5.15B | 18.03%5.17B | 22.83%5.21B | 9.07%4.65B | 2.39%4.41B | --4.38B | 8.18%4.24B |
Total assets | 12.12%8.52B | 3.92%8.21B | 9.39%8.12B | 9.77%8.05B | 3.17%7.6B | 12.26%7.9B | 10.19%7.42B | 10.36%7.34B | --7.36B | 22.83%7.04B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 346.53%670.22M | 187.61%431.68M | --511.72M | --360.2M | 399.78%150.1M | 399.78%150.1M | ---- | ---- | --30.03M | -92.52%30.03M |
Notes payable and accounts payable | 25.59%1.18B | 27.10%1.12B | 19.40%1.16B | 1.44%1.09B | -4.70%937.12M | -4.69%881.8M | -11.62%971.6M | 14.17%1.08B | --983.3M | 13.42%925.16M |
-Notes payable | 39.70%31.6M | 51.08%31.2M | 28.23%27.38M | 62.88%27.62M | 75.34%22.62M | 8.71%20.65M | -4.66%21.35M | -29.54%16.96M | --12.9M | -84.47%19M |
-Accounts payable | 25.24%1.15B | 26.53%1.09B | 19.20%1.13B | 0.46%1.06B | -5.76%914.5M | -4.97%861.15M | -11.76%950.25M | 15.32%1.06B | --970.4M | 30.69%906.16M |
Contract liabilities | -73.38%942.59K | -38.14%1.24M | -73.54%1.41M | -2.92%2.55M | -33.30%3.54M | -61.58%2M | -18.18%5.33M | -52.85%2.63M | --5.31M | 209.21%5.2M |
Advance receipts | --349.13K | -99.70%2.86K | ---- | ---- | ---- | -68.80%966.75K | ---- | 289.38%1.96M | ---- | 1,106.97%3.1M |
Salaries payable | 27.77%25.6M | 3.99%3.5M | -20.67%51.93M | -20.46%35.78M | -19.41%20.04M | 17.91%3.36M | 26.52%65.46M | 30.61%44.98M | --24.87M | 8.16%2.85M |
Taxs payable | 147.77%35.32M | -24.94%13.46M | 64.99%45.5M | -68.64%12.85M | -80.09%14.26M | -73.26%17.94M | -29.27%27.58M | -48.28%41M | --71.6M | -3.54%67.09M |
Other payable (including interest and dividends) | 104.82%376.64M | -15.80%597.13M | 22.33%484.89M | 16.29%329.25M | -32.23%183.88M | 293.18%709.16M | 107.33%396.38M | 19.40%283.13M | --271.32M | -33.73%180.37M |
-Interest payable | ---- | ---- | ---- | ---- | ---- | ---- | --466.61K | ---- | ---- | ---- |
-Other payable | ---- | ---- | ---- | 16.29%329.25M | ---- | 293.18%709.16M | ---- | --283.13M | ---- | -33.73%180.37M |
Non current liabilities due within one year | -75.34%19.89M | -89.30%8.64M | -65.44%13.59M | 52.86%62.77M | 214.00%80.64M | 210.28%80.69M | -64.78%39.33M | 163.86%41.06M | --25.68M | 131.08%26.01M |
Other current liabilities | -73.20%85.4K | -38.14%111.27K | -73.54%126.86K | -2.90%229.6K | -33.30%318.72K | -61.58%179.88K | -18.18%479.48K | -42.63%236.47K | --477.82K | 54.67%468.14K |
Total current liabilities | 65.91%2.31B | 17.90%2.18B | 50.67%2.27B | 27.11%1.89B | -1.61%1.39B | 48.85%1.85B | -13.96%1.51B | -12.12%1.49B | --1.41B | -21.26%1.24B |
Current liabilities | ||||||||||
Long term loan | -94.92%22.1M | -92.30%33.5M | -92.80%35M | -8.31%446M | -13.24%435M | -13.24%435M | -40.42%486.4M | -49.62%486.4M | --501.4M | -15.50%501.4M |
Estimate liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --20.2M | -46.32%20.2M |
Deferred tax liabilities | 31.53%220.63M | 15.88%198.42M | 91.18%160.72M | 97.94%169.04M | 104.80%167.74M | 109.20%171.23M | -2.04%84.07M | 45.85%85.4M | --81.9M | 94.77%81.85M |
Lease liabilities | -59.26%3.24M | -70.66%3.05M | -90.07%1.63M | -71.09%6.15M | -60.05%7.94M | -46.86%10.4M | -30.17%16.38M | -15.08%21.26M | --19.88M | 3.63%19.57M |
Total non current liabilities | -59.72%245.97M | -61.89%234.97M | -66.37%197.35M | 4.74%621.19M | -2.04%610.68M | -1.03%616.63M | -39.08%586.85M | -45.42%593.06M | --623.38M | -9.96%623.03M |
Total liabilities | 27.56%2.55B | -2.08%2.41B | 17.85%2.47B | 20.74%2.52B | -1.74%2B | 32.18%2.46B | -22.88%2.09B | -25.12%2.08B | --2.04B | -17.81%1.86B |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%1.31B | 0.00%1.31B | 0.00%1.31B | 0.00%1.31B | 0.00%1.31B | 0.00%1.31B | 11.11%1.31B | 11.11%1.31B | --1.31B | 11.11%1.31B |
Capital reserve funds | -0.06%2.39B | -0.07%2.39B | -0.06%2.39B | -0.03%2.39B | -0.02%2.39B | -0.01%2.39B | 59.71%2.39B | 59.70%2.39B | --2.39B | 59.68%2.39B |
Surplus reserve funds | 37.34%169.54M | 37.34%169.54M | 42.16%123.44M | 42.16%123.44M | 42.16%123.44M | 42.16%123.44M | 100.27%86.83M | 100.27%86.83M | --86.83M | 100.27%86.83M |
Retained profit | 21.43%2.06B | 23.23%1.89B | 22.81%1.79B | 20.79%1.66B | 19.38%1.7B | 21.00%1.53B | 22.89%1.45B | 32.97%1.37B | --1.42B | 97.91%1.27B |
Specific reserves | -66.51%21.14M | -58.16%29.79M | -53.16%36.51M | -40.07%49.82M | -39.29%63.13M | -33.45%71.2M | -27.60%77.94M | -18.73%83.14M | --103.98M | 18.08%107M |
Shareholders equity without minority interests | 6.56%5.95B | 6.61%5.79B | 6.12%5.65B | 5.49%5.53B | 5.10%5.59B | 5.16%5.43B | 32.67%5.32B | 36.07%5.24B | --5.32B | 49.61%5.16B |
Minority interests | 27.37%10.01M | 20.71%10.06M | -20.46%7.31M | -29.33%7M | -23.98%7.86M | -30.19%8.33M | -23.12%9.2M | -16.24%9.91M | --10.34M | -0.43%11.94M |
Total shareholder equity | 6.59%5.96B | 6.63%5.8B | 6.07%5.65B | 5.42%5.54B | 5.05%5.59B | 5.08%5.44B | 32.51%5.33B | 35.91%5.25B | --5.33B | 49.44%5.17B |
Total liabilityies and equity | 12.12%8.52B | 3.92%8.21B | 9.39%8.12B | 9.77%8.05B | 3.17%7.6B | 12.26%7.9B | 10.19%7.42B | 10.36%7.34B | --7.36B | 22.83%7.04B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.